Chapter 661: New Product Launch Part One (1/2)
Yanjing.
Xu Cheng asked Lin Dong to take a sample to Ye Xiu, and Ye Xiu took that sample to Zhou Xiaoming and the others for research.
There was only one new product in the sample this time.
A kind of scar-repairing serum.
Based on his original intensified genes, Xu Cheng added another set of Dugesia genes on top of that.
This was another new discovery that Xu Cheng had found in his body. After he had studied the Dugesia genes, he suddenly realized why his injuries had a strong regenerative ability every time he touched their secretion, it was a specific gene of theirs that played a role.
He had found that even if he cut the Dugesia into several pieces, the organism could regenerate itself. It was a pity that this kind of ability could not be transferred onto regenerative human cells, otherwise there would be no need for Xu Cheng to use his own blood as the foundation of the serum.
However, with Xu Cheng’s genes as a foundation, it did stimulate the regenerative ability of the Dugesia gene and was very effective in repairing scars on the skin. It wasn’t just scars either; any wound that hadn’t damaged the bone marrow or the bone could be repaired, even if it reached the subdermal layer.
Of course, in order to not panic people because of how unbelievable it seemed, Xu Cheng diluted the serum so that it was similar to the anti-cancer treatments in the future.
In other words, the powerful serum that could originally heal wounds within a few hours was weakened so that it would require three days to half a month for a kind of sustainable effect.
But even then, it was enough to drive the ladies crazy!
Ye Xiu, Zhou Xiaoming, and three others sat in front of a credible researcher, and they all felt shocked after hearing his report.
“This effect is too powerful! Skin necrosis is generally related to the metabolic deaths of the cells, and there has been no breakthrough in this area yet. All the skin repair treatments right now are the laser ones, but those have strong side effects and are expensive at the same time; not to mention the post-care procedures. If this drug came out on the market, I feel that many of the top brand cosmetics companies may have to close down.” The researcher sounded excited.